| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/25/2015 | EP2839839A1 Nuclear targeting sequences |
| 02/25/2015 | EP2839838A1 Fowl adenovirus vaccine |
| 02/25/2015 | EP2838919A1 Anti-mige antibodies that bind to the junction between ch4 and c epsilon mx domains |
| 02/25/2015 | EP2838562A1 Human antibodies and specific binding sequences thereof for use in stroke and ischemia or ischemic conditions |
| 02/25/2015 | EP2838561A1 Combination therapy of anti-mif antibodies and chemotherapeutics |
| 02/25/2015 | EP2838560A2 Methods of treating ankylosing spondylitis using il-17 antagonists |
| 02/25/2015 | EP2838559A1 Combination therapy of anti-mif antibodies and glucocorticoids |
| 02/25/2015 | EP2838558A1 Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor |
| 02/25/2015 | EP2838557A1 The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity |
| 02/25/2015 | EP2838556A1 Plant profilin polypeptides for use in non-specific allergy immunotherapy |
| 02/25/2015 | EP2838555A2 Vaccines and methods to treat lyme disease in dogs |
| 02/25/2015 | EP2838554A1 Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine |
| 02/25/2015 | EP2838515A1 Mesoporous silica compositions for modulating immune responses |
| 02/25/2015 | EP2838375A1 Biomass hetero-colloidal systems, production and uses thereof |
| 02/24/2015 | US8962819 Anti-C5 alpha antibodies |
| 02/24/2015 | US8962816 Constructs for enhancing immune responses |
| 02/24/2015 | US8962814 Interleukin-1α antibodies and methods of use |
| 02/24/2015 | US8962807 Single variable domain antibodies against OX40L, constructs and therapeutic use |
| 02/24/2015 | US8962806 Humanized monoclonal antibodies and methods of use |
| 02/24/2015 | US8962805 Anti IL-6R polypeptides and compositions thereof |
| 02/24/2015 | US8962801 Neisseria porin proteins |
| 02/24/2015 | US8962793 ErbB interface peptidomimetics and methods of use thereof |
| 02/24/2015 | US8962678 Senescence inhibitor |
| 02/24/2015 | US8962593 GLA monotherapy for use in cancer treatment |
| 02/24/2015 | US8962590 Prostate cancer vaccine |
| 02/24/2015 | US8962313 Method for the simultaneous induction of CTL and γδT cell |
| 02/24/2015 | US8962278 Compositions and methods for production of immunoglobulins |
| 02/24/2015 | US8962275 Anti-α5β1 antibodies and uses thereof |
| 02/24/2015 | US8962265 Mutant parasites for use as vaccines and platforms for screening for compounds |
| 02/24/2015 | US8962249 Methods for detecting and treating systemic lupus erythematous |
| 02/24/2015 | US8962010 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 02/24/2015 | US8961998 Immediate protection against pathogens via MVA |
| 02/24/2015 | US8961997 Method for purifying the rabies virus |
| 02/24/2015 | US8961996 N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 02/24/2015 | US8961995 Methods and compositions for alphavirus replicons |
| 02/24/2015 | US8961994 DNA constructs eliciting immune response against flavivirus and effective adjuvants |
| 02/24/2015 | US8961992 Epsigam fusion protein |
| 02/24/2015 | US8961991 Anti-CD40 targeted fusion proteins |
| 02/24/2015 | US8961990 Vaccine and methods to reduce campylobacter infection |
| 02/24/2015 | US8961989 Methods for producing an immune response to tuberculosis |
| 02/24/2015 | US8961988 Compositions and methods for the treatment or prevention of hepatitis B virus infection |
| 02/24/2015 | US8961987 Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies |
| 02/24/2015 | US8961986 Peptide composition |
| 02/24/2015 | US8961985 Immunotherapy against several tumors including neuronal and brain tumors |
| 02/24/2015 | US8961984 Surface-coated structures and methods |
| 02/24/2015 | US8961983 Mucosal vaccine using cationic nanogel |
| 02/24/2015 | US8961982 Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer |
| 02/24/2015 | US8961981 Targeting the neuromuscular junction for treatment |
| 02/24/2015 | US8961980 Monoclonal antibodies for treatment of cancer |
| 02/24/2015 | US8961979 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 02/24/2015 | US8961978 Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses |
| 02/24/2015 | US8961977 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/24/2015 | US8961976 Anti-CD154 antibodies |
| 02/24/2015 | US8961975 Monoclonal antibodies that neutralize anthrax toxins |
| 02/24/2015 | US8961974 Multiple-variable dose regimen for treating TNFα-related disorders |
| 02/24/2015 | US8961973 Multiple-variable dose regimen for treating TNFα-related disorders |
| 02/24/2015 | US8961972 Anti-N3pGlu amyloid beta peptide antibodies and uses thereof |
| 02/24/2015 | US8961971 Bispecific T-cell activator antibody |
| 02/24/2015 | US8961970 Combination therapy |
| 02/24/2015 | US8961969 Antagonist antibodies against EphB3 |
| 02/24/2015 | US8961968 Human monoclonal antibodies against CD25 |
| 02/24/2015 | US8961966 Antibodies against ERBB3 and uses thereof |
| 02/24/2015 | US8961965 Methods of diagnosing and treating pulmonary diseases or disorders |
| 02/24/2015 | US8961964 High concentration antibody and protein formulations |
| 02/24/2015 | US8961961 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases |
| 02/24/2015 | US8961957 Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10 |
| 02/24/2015 | CA2749862C A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 02/24/2015 | CA2708065C Therapeutic agent for pruritus |
| 02/24/2015 | CA2670965C Influenza vaccine formulation |
| 02/24/2015 | CA2663537C Il-17 receptor a antigen binding proteins |
| 02/24/2015 | CA2636288C Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 02/24/2015 | CA2594233C Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 02/24/2015 | CA2573430C Anti-perp antibody |
| 02/24/2015 | CA2539715C Pertussis antigens and use thereof in vaccination |
| 02/24/2015 | CA2489467C Humanized monoclonal antibody hpam4 |
| 02/24/2015 | CA2447695C Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/19/2015 | WO2015024022A2 Designed peptides for tight junction barrier modulation |
| 02/19/2015 | WO2015023972A1 Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant |
| 02/19/2015 | WO2015023958A1 Toll-like receptor agonists |
| 02/19/2015 | WO2015023851A1 Antibodies against frizzled proteins and methods of use thereof |
| 02/19/2015 | WO2015023836A1 Kim-1 as a therapeutic target in conditions associated with kidney fibrosis |
| 02/19/2015 | WO2015023796A2 Peptide conjugated particles |
| 02/19/2015 | WO2015023507A2 Methods for increasing forced expiratory volume in asthmatics using benralizumab |
| 02/19/2015 | WO2015023504A1 Methods for reducing exacerbation rates of asthma using benralizumab |
| 02/19/2015 | WO2015023285A1 Biomarkers for use in colorectal cancer |
| 02/19/2015 | WO2015022656A1 Methods of treating generalized pustular psoriasis (gpp) using il-17 antagonists |
| 02/19/2015 | WO2015022401A1 Immunoadjuvant compositions and uses thereof |
| 02/19/2015 | WO2015022077A1 Novel anti-fc-gamma receptor iib antibodies and uses thereof |
| 02/19/2015 | WO2015022076A1 Novel anti-fcyriib igg-type antibody |
| 02/19/2015 | WO2015021871A1 Antibody specifically binding to glp-1r and fusion protein thereof with glp-1 |
| 02/19/2015 | US20150050327 Liposome formulation suitable for treating or preventing tuberculosis |
| 02/19/2015 | US20150050319 Natural saponin-based synthetic immunoadjuvants |
| 02/19/2015 | US20150050318 Multivalent nanoemulsion vaccines |
| 02/19/2015 | US20150050317 Means for Eliciting an Immune Response and a Method Therefor |
| 02/19/2015 | US20150050312 Bacterial vaccine |
| 02/19/2015 | US20150050311 Novel method for the preparation of a strain-adapted vaccine |
| 02/19/2015 | US20150050310 Immunogens for hiv vaccination |
| 02/19/2015 | US20150050309 Vaccine |
| 02/19/2015 | US20150050308 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/19/2015 | US20150050307 Materials and methods for producing improved lentiviral vector particles |